Formycon AG Cash Flow Conversion Efficiency

Latest as of December 2025: 0.011x

Formycon AG cash flow conversion efficiency. Based on the latest financial reports, Formycon AG (FYB) has a cash flow conversion efficiency ratio of 0.011x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€4.54 Million ≈ $5.30 Million USD) by net assets (€399.14 Million ≈ $466.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Formycon AG (2009–2025)

Cash flow conversion efficiency of Formycon AG from 2009 to 2025. This chart illustrates how Formycon AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View FYB share price today for real-time trading data and today's change.

Formycon AG Cash Flow Conversion Ratio Explained

Formycon AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Formycon AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Formycon AG ranked by their cash flow conversion efficiency. Also see FYB market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
China Railway Prefabricated Construction Co Ltd SHE:300374	-0.015x
Fujian Jinsen Forestry Co Ltd SHE:002679	-0.009x
Yunnan Jinggu Forestry Co Ltd SHG:600265	-0.076x
MT Hoejgaard Holding A/S CO:MTHH	-0.027x
Shenzhen Magic Design & Decoration Engineering Co Ltd SHE:002856	0.611x
Aduro Clean Technologies Inc. Common Stock NASDAQ:ADUR	-0.062x
Shenzhen Bioeasy Biotechnology Co. Ltd. SHE:300942	0.010x
Zhejiang East Crystal Electronic Co Ltd SHE:002199	0.016x

Annual Cash Flow Conversion Efficiency for Formycon AG (2009–2025)

The table below shows the annual cash flow conversion efficiency of Formycon AG from 2009 to 2025. Review how much free cash does Formycon AG generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€399.14 Million ≈ $466.63 Million	€10.78 Million ≈ $12.61 Million	0.027x	+153.73%
2024-12-31	€461.84 Million ≈ $539.94 Million	€-23.22 Million ≈ $-27.15 Million	-0.050x	-156.68%
2023-12-31	€502.75 Million ≈ $587.77 Million	€-9.85 Million ≈ $-11.51 Million	-0.020x	+63.23%
2022-12-31	€356.58 Million ≈ $416.88 Million	€-18.99 Million ≈ $-22.21 Million	-0.053x	+78.01%
2021-12-31	€55.89 Million ≈ $65.34 Million	€-13.54 Million ≈ $-15.83 Million	-0.242x	-216.50%
2020-12-31	€68.04 Million ≈ $79.54 Million	€-5.21 Million ≈ $-6.09 Million	-0.077x	-145.04%
2019-12-31	€48.21 Million ≈ $56.36 Million	€-1.51 Million ≈ $-1.76 Million	-0.031x	-107.81%
2018-12-31	€33.24 Million ≈ $38.86 Million	€13.30 Million ≈ $15.55 Million	0.400x	+345.01%
2017-12-31	€25.54 Million ≈ $29.86 Million	€-4.17 Million ≈ $-4.88 Million	-0.163x	+32.29%
2016-12-31	€20.89 Million ≈ $24.42 Million	€-5.04 Million ≈ $-5.89 Million	-0.241x	-1260.19%
2015-12-31	€24.87 Million ≈ $29.08 Million	€517.00K ≈ $604.43K	0.021x	+981.57%
2014-12-31	€13.64 Million ≈ $15.95 Million	€-32.17K ≈ $-37.61K	-0.002x	+99.83%
2013-12-31	€12.25 Million ≈ $14.32 Million	€-16.65 Million ≈ $-19.47 Million	-1.359x	-368.19%
2012-12-31	€4.26 Million ≈ $4.98 Million	€2.16 Million ≈ $2.52 Million	0.507x	+6644.70%
2011-12-31	€5.14 Million ≈ $6.01 Million	€38.60K ≈ $45.13K	0.008x	+101.07%
2010-12-31	€4.07 Million ≈ $4.76 Million	€-2.85 Million ≈ $-3.33 Million	-0.700x	+8.21%
2009-12-31	€640.00K ≈ $748.23K	€-487.93K ≈ $-570.44K	-0.762x	--

About Formycon AG

XETRA:FYB Germany Biotechnology

Market Cap

$389.26 Million

€332.96 Million EUR

Market Cap Rank

#13960 Global

#1433 in Germany

Share Price

€18.84

Change (1 day)

-0.21%

52-Week Range

€16.82 - €26.10

All Time High

€92.50